INTUITIVE SURGICAL INC (1ISRG.MI) Fundamental Analysis & Valuation

BIT:1ISRG • US46120E6023

Current stock price

419.4 EUR
+8.55 (+2.08%)
Last:

This 1ISRG.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. 1ISRG.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1ISRG was profitable.
  • 1ISRG had a positive operating cash flow in the past year.
  • In the past 5 years 1ISRG has always been profitable.
  • Each year in the past 5 years 1ISRG had a positive operating cash flow.
1ISRG.MI Yearly Net Income VS EBIT VS OCF VS FCF1ISRG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 13.96%, 1ISRG belongs to the top of the industry, outperforming 95.16% of the companies in the same industry.
  • 1ISRG's Return On Equity of 16.02% is amongst the best of the industry. 1ISRG outperforms 87.10% of its industry peers.
  • 1ISRG has a better Return On Invested Capital (13.95%) than 90.32% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1ISRG is above the industry average of 10.01%.
  • The last Return On Invested Capital (13.95%) for 1ISRG is above the 3 year average (12.43%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.96%
ROE 16.02%
ROIC 13.95%
ROA(3y)12.67%
ROA(5y)12.15%
ROE(3y)14.56%
ROE(5y)13.99%
ROIC(3y)12.43%
ROIC(5y)12.44%
1ISRG.MI Yearly ROA, ROE, ROIC1ISRG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • The Profit Margin of 1ISRG (28.38%) is better than 98.39% of its industry peers.
  • 1ISRG's Profit Margin has improved in the last couple of years.
  • 1ISRG has a Operating Margin of 29.35%. This is amongst the best in the industry. 1ISRG outperforms 96.77% of its industry peers.
  • 1ISRG's Operating Margin has improved in the last couple of years.
  • 1ISRG has a better Gross Margin (66.00%) than 72.58% of its industry peers.
  • In the last couple of years the Gross Margin of 1ISRG has remained more or less at the same level.
Industry RankSector Rank
OM 29.35%
PM (TTM) 28.38%
GM 66%
OM growth 3Y4.58%
OM growth 5Y3.73%
PM growth 3Y10.12%
PM growth 5Y3.12%
GM growth 3Y-0.72%
GM growth 5Y0.11%
1ISRG.MI Yearly Profit, Operating, Gross Margins1ISRG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. 1ISRG.MI Health Analysis

2.1 Basic Checks

  • 1ISRG has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for 1ISRG has been reduced compared to 1 year ago.
  • Compared to 5 years ago, 1ISRG has more shares outstanding
  • 1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
1ISRG.MI Yearly Shares Outstanding1ISRG.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
1ISRG.MI Yearly Total Debt VS Total Assets1ISRG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

  • 1ISRG has an Altman-Z score of 41.10. This indicates that 1ISRG is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 41.10, 1ISRG belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • There is no outstanding debt for 1ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 41.1
ROIC/WACC1.32
WACC10.59%
1ISRG.MI Yearly LT Debt VS Equity VS FCF1ISRG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • 1ISRG has a Current Ratio of 4.87. This indicates that 1ISRG is financially healthy and has no problem in meeting its short term obligations.
  • 1ISRG has a better Current ratio (4.87) than 95.16% of its industry peers.
  • 1ISRG has a Quick Ratio of 3.96. This indicates that 1ISRG is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 3.96, 1ISRG belongs to the top of the industry, outperforming 95.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.87
Quick Ratio 3.96
1ISRG.MI Yearly Current Assets VS Current Liabilites1ISRG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. 1ISRG.MI Growth Analysis

3.1 Past

  • 1ISRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.83%, which is quite impressive.
  • Measured over the past years, 1ISRG shows a very strong growth in Earnings Per Share. The EPS has been growing by 21.42% on average per year.
  • The Revenue has grown by 20.51% in the past year. This is a very strong growth!
  • The Revenue has been growing by 18.22% on average over the past years. This is quite good.
EPS 1Y (TTM)21.83%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%14.48%
Revenue 1Y (TTM)20.51%
Revenue growth 3Y17.39%
Revenue growth 5Y18.22%
Sales Q2Q%18.76%

3.2 Future

  • 1ISRG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.00% yearly.
  • Based on estimates for the next years, 1ISRG will show a quite strong growth in Revenue. The Revenue will grow by 12.91% on average per year.
EPS Next Y14.46%
EPS Next 2Y14.31%
EPS Next 3Y14.59%
EPS Next 5Y14%
Revenue Next Year15.92%
Revenue Next 2Y14.87%
Revenue Next 3Y14.63%
Revenue Next 5Y12.91%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
1ISRG.MI Yearly Revenue VS Estimates1ISRG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B
1ISRG.MI Yearly EPS VS Estimates1ISRG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20

More info and screens

Find the best growth stocksShow best growing peers

2

4. 1ISRG.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 54.26, the valuation of 1ISRG can be described as expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of 1ISRG indicates a slightly more expensive valuation: 1ISRG is more expensive than 62.90% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.23. 1ISRG is valued rather expensively when compared to this.
  • 1ISRG is valuated quite expensively with a Price/Forward Earnings ratio of 47.41.
  • Based on the Price/Forward Earnings ratio, 1ISRG is valued a bit more expensive than the industry average as 69.35% of the companies are valued more cheaply.
  • The average S&P500 Price/Forward Earnings ratio is at 22.42. 1ISRG is valued rather expensively when compared to this.
Industry RankSector Rank
PE 54.26
Fwd PE 47.41
1ISRG.MI Price Earnings VS Forward Price Earnings1ISRG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 1ISRG is valued a bit more expensive than the industry average as 66.13% of the companies are valued more cheaply.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as 1ISRG.
Industry RankSector Rank
P/FCF 69.1
EV/EBITDA 45
1ISRG.MI Per share data1ISRG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1ISRG does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of 1ISRG may justify a higher PE ratio.
  • 1ISRG's earnings are expected to grow with 14.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.75
PEG (5Y)2.53
EPS Next 2Y14.31%
EPS Next 3Y14.59%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 1ISRG.MI Dividend Analysis

5.1 Amount

  • No dividends for 1ISRG!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

1ISRG.MI Fundamentals: All Metrics, Ratios and Statistics

INTUITIVE SURGICAL INC

BIT:1ISRG (3/16/2026, 7:00:00 PM)

419.4

+8.55 (+2.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22
Earnings (Next)04-20
Inst Owners88.29%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap148.94B
Revenue(TTM)10.06B
Net Income(TTM)2.86B
Analysts78.1
Price Target533.94 (27.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.28%
Min EPS beat(2)9.85%
Max EPS beat(2)18.71%
EPS beat(4)4
Avg EPS beat(4)10.81%
Min EPS beat(4)3.05%
Max EPS beat(4)18.71%
EPS beat(8)8
Avg EPS beat(8)11.52%
EPS beat(12)12
Avg EPS beat(12)8.73%
EPS beat(16)14
Avg EPS beat(16)6.39%
Revenue beat(2)2
Avg Revenue beat(2)2.19%
Min Revenue beat(2)2.17%
Max Revenue beat(2)2.22%
Revenue beat(4)4
Avg Revenue beat(4)1.83%
Min Revenue beat(4)1.09%
Max Revenue beat(4)2.22%
Revenue beat(8)5
Avg Revenue beat(8)1.43%
Revenue beat(12)7
Avg Revenue beat(12)0.96%
Revenue beat(16)9
Avg Revenue beat(16)0.46%
PT rev (1m)4.89%
PT rev (3m)2.43%
EPS NQ rev (1m)0.17%
EPS NQ rev (3m)0.31%
EPS NY rev (1m)3%
EPS NY rev (3m)3.32%
Revenue NQ rev (1m)0.53%
Revenue NQ rev (3m)0.53%
Revenue NY rev (1m)1.01%
Revenue NY rev (3m)1.05%
Valuation
Industry RankSector Rank
PE 54.26
Fwd PE 47.41
P/S 17.1
P/FCF 69.1
P/OCF 56.79
P/B 9.66
P/tB 9.87
EV/EBITDA 45
EPS(TTM)7.73
EY1.84%
EPS(NY)8.85
Fwd EY2.11%
FCF(TTM)6.07
FCFY1.45%
OCF(TTM)7.39
OCFY1.76%
SpS24.53
BVpS43.44
TBVpS42.49
PEG (NY)3.75
PEG (5Y)2.53
Graham Number86.92
Profitability
Industry RankSector Rank
ROA 13.96%
ROE 16.02%
ROCE 16.01%
ROIC 13.95%
ROICexc 20.73%
ROICexgc 21.4%
OM 29.35%
PM (TTM) 28.38%
GM 66%
FCFM 24.75%
ROA(3y)12.67%
ROA(5y)12.15%
ROE(3y)14.56%
ROE(5y)13.99%
ROIC(3y)12.43%
ROIC(5y)12.44%
ROICexc(3y)18.4%
ROICexc(5y)18.81%
ROICexgc(3y)19.07%
ROICexgc(5y)19.65%
ROCE(3y)14.27%
ROCE(5y)14.28%
ROICexgc growth 3Y2.03%
ROICexgc growth 5Y0.92%
ROICexc growth 3Y2.86%
ROICexc growth 5Y2.05%
OM growth 3Y4.58%
OM growth 5Y3.73%
PM growth 3Y10.12%
PM growth 5Y3.12%
GM growth 3Y-0.72%
GM growth 5Y0.11%
F-Score8
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 79.72%
Cap/Sales 5.36%
Interest Coverage 250
Cash Conversion 83.46%
Profit Quality 87.21%
Current Ratio 4.87
Quick Ratio 3.96
Altman-Z 41.1
F-Score8
WACC10.59%
ROIC/WACC1.32
Cap/Depr(3y)178.7%
Cap/Depr(5y)155.64%
Cap/Sales(3y)11.2%
Cap/Sales(5y)9.67%
Profit Quality(3y)61.68%
Profit Quality(5y)71.87%
High Growth Momentum
Growth
EPS 1Y (TTM)21.83%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%14.48%
EPS Next Y14.46%
EPS Next 2Y14.31%
EPS Next 3Y14.59%
EPS Next 5Y14%
Revenue 1Y (TTM)20.51%
Revenue growth 3Y17.39%
Revenue growth 5Y18.22%
Sales Q2Q%18.76%
Revenue Next Year15.92%
Revenue Next 2Y14.87%
Revenue Next 3Y14.63%
Revenue Next 5Y12.91%
EBIT growth 1Y25.34%
EBIT growth 3Y22.76%
EBIT growth 5Y22.63%
EBIT Next Year34.54%
EBIT Next 3Y22.15%
EBIT Next 5Y17.41%
FCF growth 1Y91.03%
FCF growth 3Y37.49%
FCF growth 5Y16.85%
OCF growth 1Y25.49%
OCF growth 3Y26.68%
OCF growth 5Y15.34%

INTUITIVE SURGICAL INC / 1ISRG.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?

ChartMill assigns a fundamental rating of 7 / 10 to 1ISRG.MI.


What is the valuation status of INTUITIVE SURGICAL INC (1ISRG.MI) stock?

ChartMill assigns a valuation rating of 2 / 10 to INTUITIVE SURGICAL INC (1ISRG.MI). This can be considered as Overvalued.


Can you provide the profitability details for INTUITIVE SURGICAL INC?

INTUITIVE SURGICAL INC (1ISRG.MI) has a profitability rating of 9 / 10.


Can you provide the PE and PB ratios for 1ISRG stock?

The Price/Earnings (PE) ratio for INTUITIVE SURGICAL INC (1ISRG.MI) is 54.26 and the Price/Book (PB) ratio is 9.66.


Can you provide the financial health for 1ISRG stock?

The financial health rating of INTUITIVE SURGICAL INC (1ISRG.MI) is 9 / 10.